Accentia Biopharmaceuticals

Accentia Biopharmaceuticals

Advanced Immunotherapeutics

FREQUENTLY ASKED QUESTIONS Accentia Biopharmaceuticals Stock Trading Symbol
  1. When was Accentia incorporated?
  2. On what exchange is Accentia traded, and what is the trading symbol?
  3. When does Accentia's fiscal year end?
  4. Does Accentia offer a direct stock purchase program?
  5. Does Accentia issue dividends?
  6. Who can I speak with regarding my specific questions?

1. When was Accentia incorporated?

Accentia was incorporated in the State of Florida in 2002.

2. On what exchange is Accentia traded, and what is the trading symbol?

Accentia is listed on the "Other OTC Market", also known as the "Pink Sheets", and is traded under the symbol "ABPIQ". The "Q" in Accentia's trading symbol denotes that the Company is currently operating under Chapter 11 reorganization proceedings. Accentia's majority-owned subsidiary, Biovest International is also publicly-traded on the Over-the-Counter Bulletin Board under the symbol "BVTIE". For more information on the Pink Sheets, please visit: www.pinksheets.com

3. When does Accentia’s fiscal year end?

Accentia's fiscal year ends on September 30.

4. Does Accentia offer a direct stock purchase program?

Accentia does not offer a direct stock purchase program at this time. Shares can only be acquired or disposed through a registered stock brokerage firm.

5. Does Accentia issue dividends?

Accentia does not currently issue a dividend, and does not anticipate doing so in the foreseeable future, as working capital is devoted to the development and regulatory strategies designed to advance our health care products to market.

6. Who can I speak with regarding my specific questions?

Please call or email Accentia's Investor Relations Officer, Douglas Calder, at (813) 864-2558 or at dwcalder@accentia.net.

Back to FAQ List